IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria

Br J Dermatol. 2018 Sep;179(3):776-777. doi: 10.1111/bjd.16593. Epub 2018 Jun 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease / drug therapy
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Immunoglobulin E / blood*
  • Male
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Treatment Outcome
  • Urticaria / blood
  • Urticaria / drug therapy*
  • Young Adult

Substances

  • Anti-Allergic Agents
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Omalizumab
  • Immunoglobulin E